Litcius/Paper detail

Single-Cell Transcriptome Analysis Reveals the M2 Macrophages and Exhausted TCells and Intratumoral Heterogeneity in Triple-Negative Breast Cancer

Lingyun Xu, Chen Li

2021Anti-Cancer Agents in Medicinal Chemistry12 citationsDOI

Abstract

BACKGROUND: Triple-Negative Breast Cancer (TNBC) is a highly heterogeneous and invasive malignancy that is characterized by high recurrence and mortality rates as well as extremely poor prognosis. OBJECTIVE: The objective of this study is to analyze T cells and Macrophages in the tumor microenvironment with the aim of identifying targets with therapeutic potential. METHODS: Single-cell sequencing data of TNBC patients from the GSE118389 dataset were analyzed to examine the immune environment and intratumoral heterogeneity of TNBC patients. RESULTS: Polarized alternatively activated macrophages (M2) and exhausted CD8+ T cells were identified in TNBC patients. Immunosuppressive checkpoint analysis revealed that levels of lymphocyte-activation gene 3 (LAG3) and T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) of exhausted T cells were significantly higher than levels of programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyteassociated protein 4 (CTLA-4). This indicates that these markers are potential immunotherapy targets. Furthermore, analysis of significantly altered immune cell markers showed that several markers were associated with the prognosis of TNBC. CONCLUSION: Overall, these findings demonstrate inter-tissue heterogeneity of TNBC, and provides novel therapeutic targets for the treatment of TNBC.

Topics & Concepts

Triple-negative breast cancerCancer researchCytotoxic T cellCD8Tumor microenvironmentImmune systemT cellImmunotherapyBiologyBreast cancerImmunologyMedicineCancerInternal medicineIn vitroBiochemistryCancer Immunotherapy and BiomarkersImmune cells in cancerSingle-cell and spatial transcriptomics
Single-Cell Transcriptome Analysis Reveals the M2 Macrophages and Exhausted TCells and Intratumoral Heterogeneity in Triple-Negative Breast Cancer | Litcius